IP Library Granted Patent US 10,557,847
Granted Patent B2
US 10,557,847 · App. 15/100,997 · Granted Feb 11, 2020

Nano-plasmonic sensor for exosome detection

Inventors: Ralph Weissleder (West Peabody, MA); Hakho Lee (Acton, MA); Hyungsoon Im (Peabody, MA); Cesar Castro (Cambridge, MA)
Assignee: THE GENERAL HOSPITAL CORPORATION
G01N33/54373G01N33/553G01N33/57449G01N2333/70596
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,557,847
App. No.
15/100,997
Granted
Feb 11, 2020
Kind
B2
Abstract

Disclosed herein are compositions and methods for exosome detection with high sensitivity by using a nano-plasmonic sensor. The nano-plasmonic sensor comprises a plurality of nanoapertures suitable for transmission measurements. The detection sensitivity is on the order of 10 4 -fold higher than western blotting and 10 2 -fold higher than enzyme-linked immunosorbent assay (ELISA). A portable imaging system is also disclosed, enabling rapid and high-throughput detection of exosomes. The nano-plasmonic sensor and imaging system can be useful in diagnostics.

Claims (29)

1. A nano-plasmonic sensor for detecting exosomes comprising,

a) a transparent planar substrate;

b) a metal film disposed onto one surface of the substrate, wherein the metal film comprises a plurality of nanoapertures in a predefined pattern to create a sensing area that produces surface plasmon resonance upon illumination;

c) a molecular spacer directly attached to the metal film, wherein the molecular spacer comprises long-chain PEG and short-chain PEG in a ratio of about 1:3; and

d) a linking agent directly attached to the molecular spacer and directly attached to a capture agent, wherein the capture agent specifically binds to an exosome marker.

2. The nano-plasmonic sensor of claim 1 , wherein the metal film comprises a noble metal, a transition metal, an alkali metal, or any combination thereof.

3. The nano-plasmonic sensor of claim 2 , wherein the substrate comprises glass, quartz, diamond, or a polymer.

4. The nano-plasmonic sensor of claim 3 , wherein the metal film comprises gold and the substrate comprises glass.

5. The nano-plasmonic sensor of claim 4 , wherein the metal film is between 50 to 500 nm thick.

6. The nano-plasmonic sensor of claim 5 , further comprising an adhesion layer located between the metal film and the substrate surface.

7. The nano-plasmonic sensor of claim 6 , wherein the adhesion layer is less than about 50 nm thick.

8. The nano-plasmonic sensor of claim 7 , wherein the predefined pattern is periodic.

9. The nano-plasmonic sensor of claim 8 , wherein the nanoapertures have a dimension and periodicity that produce an electromagnetic field with a decay length of about 50 nm to 200 nm when the nanoapertures are illuminated by light with a wavelength close to or at the surface plasmon resonance.

10. The nano-plasmonic sensor of claim 9 , wherein the nanoapertures are circular, elliptical, rectangular, triangular, oval, or hexagonal.

11. The nano-plasmonic sensor of claim 10 , wherein the circular nanoapertures are about 50 nm to 300 nm in diameter, and wherein the periodicity is about 400 nm to 700 nm.

12. The nano-plasmonic sensor of claim 11 , wherein the circular nanoapertures are about 200 nm in diameter, and wherein the periodicity is about 450 nm to 500 nm.

13. The nano-plasmonic sensor of claim 1 , wherein the linking agent comprises protein A/G or neutravidin.

14. A method of detecting exosomes in a sample, comprising

a) introducing a sample suspected of containing one or more exosomes onto a nano-plasmonic sensor of claim 1 under conditions which promote binding of the exosomes to the sensor;

b) washing the sensor to remove unbound materials;

c) illuminating the sensor to thereby transmit light through the sensor;

d) measuring the light transmitted through the sensor to identify a significant change from that of a negative control; and

e) detecting exosomes in the sample when the significant change m the transmitted light is identified.

15. The method of claim 14 , wherein the negative control is a solution substantially free of exosomes or exosome lysates.

16. The method of claim 14 , wherein the change is a shift in peak wavelength.

17. A method for determining an expression level of a target marker in a sample of exosomes, comprising:

a) detecting total exosomes in the sample by the method of claim 14 , using a capture agent that specifically binds a pan-exosomal marker;

b) detecting exosomes in the sample expressing the target marker by the method of claim 14 using a capture agent that specifically binds the target marker; and

c) calculating the ratio of exosomes with the target marker to total exosomes to thereby indicate the average expression level of the target marker per exosome from the sample.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 2, 2020
From: MASSACHUSETTS GENERAL HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052806/0263 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2016
From: WEISSLEDER, RALPH; LEE, HAKHO; IM, HYUNGSOON; CASTRO, CESAR
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 040492/0620 →
Continuity (2)
Provisional Application 61910782 · Dec 2, 2013
Related Publication 20160334398A1 · Nov 17, 2016
Cited By (2)
US 12,498,321 US 12,613,188